Rabies Vaccine (Human Diploid Cell) for Human Use, Freeze-dried (HDCV)
Classification:
Products in the Pipeline
- Product Description
- Immunogenicity
- Security
- Mad Dog Bite Cases
-
Manufacturing Process
The project utilizes an automated multi-axis robotic intelligent manufacturing technology platform to ensure the purity of the active ingredient, effectively control the contamination in the manufacturing process, and achieve the application of cell factory technology in rabies vaccine production.
Current Progress
Phase III clinical trial has been completed on HDCV, and submitted an application for drug marketing authorization.
Previous Page
Previous Page
Other Products
Inactivated Japanese Encephalitis Vaccine for Human Use (Vero cell) (IJEV)
SPEEDA-Rabies Vaccine for Human Use (Vero cell) (CPRV)
Rabies Vaccine (Human Diploid Cell) for Human Use, Freeze-dried (HDCV)
Influenza Vaccine (Split Virion), Inactivated, Quadrivalent (QIV)
13-valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV 13)
Recombinant Human Papillomavirus 15-valent Vaccine (Escherichia. Coli) (HPV 15)
Follow us
Telephone
Marketing Center
International Trade
Medical Consultation
Address
No.1, XinFang Street, Hunnan New District, Shenyang City
123456789
12456789